WO2007063648A1 - Agent for improving obesity conditions - Google Patents

Agent for improving obesity conditions Download PDF

Info

Publication number
WO2007063648A1
WO2007063648A1 PCT/JP2006/320476 JP2006320476W WO2007063648A1 WO 2007063648 A1 WO2007063648 A1 WO 2007063648A1 JP 2006320476 W JP2006320476 W JP 2006320476W WO 2007063648 A1 WO2007063648 A1 WO 2007063648A1
Authority
WO
WIPO (PCT)
Prior art keywords
obesity
essential oil
agent
improving
polyoxyethylene
Prior art date
Application number
PCT/JP2006/320476
Other languages
French (fr)
Japanese (ja)
Inventor
Ken Harada
Chiho Motonaga
Kiyohito Sawano
Kazutoshi Sakurai
Hidetsuna Watanabe
Seiji Kawano
Original Assignee
Kose Corporation
Takasago International Corporation
Fukushima University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kose Corporation, Takasago International Corporation, Fukushima University filed Critical Kose Corporation
Priority to JP2007547866A priority Critical patent/JP5814495B2/en
Priority to TW095144356A priority patent/TW200730185A/en
Publication of WO2007063648A1 publication Critical patent/WO2007063648A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/14Cupressaceae (Cypress family), e.g. juniper or cypress
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00Formulations or additives for perfume preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/06Preparations for care of the skin for countering cellulitis

Definitions

  • the present invention relates to an obesity improving agent comprising a specific essential oil or synthetic fragrance, and a skin external preparation and fragrance containing the same.
  • Mass Index Weight (kg) Z Height 2 (m)) is 25 or more.
  • a skin external preparation containing a so-called slimming agent is directly applied to human skin, a food containing a slimming agent is taken, and a body soap containing a slimming agent is used to treat the body.
  • the method of cleaning is an effective method that eliminates problems such as giving a feeling of mental pressure.
  • Specific techniques include, for example, a method of adding cognac oil or mate oil to an external preparation for skin or food (Patent Document 1), from grapefruit oil to limonate.
  • Patent Document 2 there is a method of adding modified grapefruit oil from which LOO mass% is removed to a cosmetic or food.
  • Patent Document 3 describes that one or more selected from limonene, vinylene, myrcene and benzylbenzoate, which are known as synthetic fragrances, are used as a fragrance for slimming.
  • synthetic fragrances which are known as synthetic fragrances.
  • that document only exemplifies those fragrances, and the above fragrance alone or a mixture of the above fragrances itself is not used as a fragrance for slimming in the examples.
  • the fragrance is merely exemplified as a slimming fragrance, and is only to the extent that it is unclear how effective it is as a slimming fragrance.
  • Patent Document 4 describes a cypress essential oil as an example of an activity-enhancing essential oil.
  • Patent Document 5 discloses a jelly-like food having a relaxed effect containing a herb extract as a plant extract, and Cypress essential oil is disclosed as a herb extract. There is no description that Cypress essential oil has an effect of improving obesity.
  • Patent Document 6 describes a mixture comprising lavender essential oil, rosemary essential oil or bergamot essential oil, lemon essential oil or lime essential oil, cypress essential oil or juicer essential oil, and carrier oil. The mixture is described as having an effect of improving facial contours by quickly and thoroughly removing excess fat on the facial surface.
  • lemon essential oil, rosemary essential oil, and lavender essential oil have been described to suggest fat removal, but cypress essential oil has no description to suggest such a point.
  • Patent Document 1 Japanese Patent Application Laid-Open No. 2005-68176
  • Patent Document 2 JP-A-2005-194252
  • Patent Document 3 Japanese Patent Laid-Open No. 2002-265977
  • Patent Document 4 Japanese Patent Publication No. 7-57734
  • Patent Document 5 Japanese Patent Laid-Open No. 2003-245048
  • Patent Document 6 Chinese Patent Publication No. 1247735
  • an object of the present invention is to provide an excellent agent for improving obesity state.
  • Another object of the present invention is to provide an agent for improving obesity status, which is an excellent agent for improving obesity status, which has both an antidepressant action and Z or stress reduction action, and is easy to prepare.
  • the invention of claim 1 is an obesity improving agent characterized by comprising a cypress essential oil.
  • the invention of claim 1 is also an obesity improving agent characterized in that it contains cypress essential oil.
  • the invention of claim 1 is an obesity improving agent characterized by containing cypress essential oil as an active ingredient.
  • the invention of claim 2 is an obesity-condition improving agent characterized by having a ⁇ 3 -force force.
  • the invention of claim 2 is also an obesity condition improving agent characterized by containing ⁇ 3 -strength.
  • the invention of claim 2 is an obesity condition improving agent characterized by containing ⁇ 3 -strength as an active ingredient.
  • the invention of claim 3 is characterized in that in the invention of claim 1 or 2, it further has an antidepressant action and a wrinkle or stress reducing action. That is, the obesity condition-improving agent is further characterized by having an antidepressant action, the obesity condition-improving agent is further having a stress-reducing action, and the obesity condition-improving agent is characterized by an antidepressant action and It further has a stress reducing effect.
  • the invention of claim 3 is also an invention characterized in that, in the invention of claim 1 or 2, the obesity state is improved by an antidepressant action and an epilepsy or stress reducing action.
  • the invention of claim 4 is an external preparation for skin containing the obesity condition-improving agent of any one of claims 1 to 3, and the invention of claim 5 is any of claims 1 to 3.
  • the A fragrance comprising an obesity-condition improving agent.
  • the invention of claim 6 is an invention of a method of using a fragrance containing cypress essential oil or ⁇ 3-strength for improving obesity.
  • the obesity condition-improving agent of the present invention As one of the functions of the obesity condition-improving agent of the present invention, the obesity condition disappears from the obesity condition, that is, the phenomenon is slimming. Therefore, the obesity condition-improving agent of the present invention is expressed as a slimming agent. You can also.
  • the cypress essential oil in the present invention is a known essential oil, and an Italian cypress essential oil is particularly preferable.
  • the Italian cypress essential oil can be prepared from a cypress plant of the genus Cypressaceae by a conventional method, but a commercially available product may be purchased.
  • the ⁇ 3-force len in the present invention is a known synthetic fragrance compound, and can be obtained by extraction from a natural product, or obtained by a biochemical synthesis method or a known chemical synthesis method. You can also purchase a commercial product.
  • a feature of the present invention is that the above-mentioned Cypress essential oil or ⁇ 3-strength is used as an obesity improving agent.
  • the improvement of obesity state here means reducing the degree of obesity, and also includes maintaining the degree of obesity. Therefore, the agent for improving obesity condition is an agent having the property 'function of reducing the degree of obesity and also includes an agent for maintaining the degree of obesity.
  • the obesity condition-improving agent of the present invention further has an antidepressant action and an epilepsy or stress-reducing action.
  • the antidepressant action is well known in the pre-application, and there are various causes and reasons for depression, and one person is able to change the condition as much as possible.
  • the stress reduction effect is also well known before the filing of this application. For example, it refers to the human power that has received stress due to the influence of the complex social environment in recent years.
  • the agent for improving obesity condition in the present invention may be added with other binders as long as the intended purpose can be achieved. These compounding agents will be described later.
  • the obesity condition-improving agent of the present invention may be contained in an external preparation for skin.
  • external preparations for skin include emulsions, creams, lotions, cosmetics, packs, facial cleansers, body soaps, makeup agents, bath preparations, fragrances, shampoos, hair treatments, hair styling agents, hair nourishing agents, hair restorers, etc. (Including medicated cosmetics), ointments, patches, patches Any of external medicines such as pills and liniments may be used.
  • the amount of the external preparation for skin to contain the agent for improving obesity condition of the present invention cannot be defined unconditionally because the optimal range differs depending on the external preparation for skin, but for example, 0.1% for external preparation for skin. It is preferable to contain ⁇ 20% by weight. 0.1 ⁇ : It is more preferred to contain L0% by weight.
  • the obesity condition-improving agent of the present invention can also be incorporated into oral care products such as toothpaste and mouthwash, foods and the like.
  • the compounding amount of the obesity condition improving agent is not particularly limited. For example, it is preferable to contain 0.1 to 20% by weight with respect to the product, food, etc. 0.1 to 10% by weight is more preferable. preferable.
  • the obesity condition-improving agent of the present invention can be contained in a fragrance such as a room fragrance, a car fragrance, an aroma candle, an aroma oil, etc. as it is or by mixing and mixing with other ingredients. .
  • the amount of the fragrance containing the agent for improving obesity condition of the present invention cannot be generally specified because the optimum range varies depending on the fragrance, but for example, 0.5 to: It is preferable to contain L00% by weight.
  • the present invention provides a composition for improving obesity which consists essentially of cypress essential oil and base power. Also provided is a composition for improving obesity which is essentially composed of ⁇ 3 -strength and a base.
  • the base means a substance that can carry Cypress essential oil or ⁇ 3 -strength, and any substance that can carry Cypress essential oil or ⁇ 3 -strength is used. Is possible. Representative examples include, but are not limited to, various solvents such as alcohols and various oils such as petrolatum.
  • the present invention also provides a method of using a fragrance containing cypress essential oil or ⁇ 3-strength to improve obesity.
  • a method of using a fragrance containing cypress essential oil or ⁇ 3-strength to improve obesity include a method of evaporating a fragrance containing cypress essential oil or ⁇ 3 -strength in a space where a person lives to improve obesity.
  • spaces in which people live include, but are not limited to, spaces in offices, health maintenance, and, in some cases, fitness spaces for beauty and living spaces such as in living rooms and bathrooms.
  • the method can also be said to be the use of cypress essential oils or fragrances containing ⁇ -3-carene as an environmental flared lance to improve obesity.
  • the method of volatilization is not particularly limited, and a fragrance containing Cypress essential oil or ⁇ 3-power lenght is volatilized at a predetermined site in the aeration apparatus. And a method of volatilizing in the space together with air, a method of arranging an arbitrary fragrance volatilization device in the space, and volatilizing perfume containing Cypress essential oil or ⁇ 3 -power len in the space, and the like.
  • peppermint essential oil also has an improvement in obesity status, although it is not as effective as an obesity improvement agent as Cypress essential oil or ⁇ 3 -strength.
  • a conventional compounding agent may be added to the external preparation for skin or fragrance according to the present invention.
  • These added ingredients include water (purified water, hot spring water, deep water, ion-exchanged water, etc.) and solvents (alcohols, polyhydric alcohols, etc.) that are commonly used in preparations for external preparations for skin and external medicine Etc.)
  • surfactant examples include polyoxyethylene glyceryl fatty acid esters such as polyoxyethylene monostearate glyceryl and polyoxyethylene monooleate glyceryl; monomyristate hexaglyceryl, monolaurate decaglyceryl, monostearate Polyglycerin fatty acid esters such as decaglyceryl acid; Polyoxyethylene monomyristate Polyoxyethylene sorbitan fatty acid esters such as sorbitan polyoxyethylene monostearate, sorbitan polyoxyethylene tristearate; Polyoxyethylene hydrogenated castor oil, polyoxyethylene Polyoxyethylene hardened castor oil such as hardened castor oil; polyoxyethylene cholesteryl ether, polyoxyethylene cholesteryl ether, etc.
  • polyoxyethylene glyceryl fatty acid esters such as polyoxyethylene monostearate glyceryl and polyoxyethylene monooleate glyceryl
  • Polyoxyethylene cholesteryl ethers polyoxyethylene phytosteryl ethers, polyoxyethylene phytosteryl ethers such as polyoxyethylene phytosteryl ethers; polyethylene glycol fatty acid esters such as polyoxyethylene glycol monolaurate and polyoxyethylene glycol monostearate; Polyoxyethylene alkyl ethers such as polyoxyethylene lauryl ether, polyoxyethylene benoyl ether, polyoxyethylene cetyl ether, polyoxyethylene stearyl ether; polyoxyethylene polyoxypropylene cetyl ether, polyethylene Examples include polyoxyethylene polyoxypropylene alkyl ethers such as reoxyethylene polyoxypropylene tetradecyl ether; polyoxyethylene alkyl ethers such as polyoxyethylene nonyl phenyl ether and polyoxyethylene octyl phenyl ether; .
  • fatty acid salts such as sodium laurate, sodium myristate, and sodium palmitate
  • polyoxyethylene such as sodium polyoxyethylene lauryl ether, sodium polyoxyethylene cetyl ether, sodium dipolyoxyethylene cetyl ether phosphate Ethyl alkyl ether phosphates
  • Acyl taurine salts such as sodium cocoyl methyl taurate and sodium stearoyl methyl taurate
  • Alkyl sulfates such as sodium lauryl sulfate and sodium cetyl sulfate
  • Sodium polyoxyethylene lauryl ether sulfate, Polyoxyethylene urea ether Examples thereof include polyoxyethylene alkyl ether sulfates such as sodium sulfate. You can use one or more of these!
  • a polyoxyethylene unit is about 3-60.
  • Examples of the high molecular weight compound include gum arabic, xanthan gum, tara gum, gati gum, carrageenan, cara gum, guar gum, tamarind seed gum, methyl cellulose, hydroxy methenoresenolellose, hydroxy ethyl cellulose, polyvinyl alcohol, hydroxy pour cellulose , Carboxymethyl cellulose, etc .; (meth) acrylic acid '(meth) acrylic acid alkyl copolymer, (meth) acrylic acid alkyl. Styrene copolymer, poly (acetate butyl), butylpyrrolidone.
  • Styrene copolymer acrylic-silicone copolymer Polymers of polymers, trimethylsiloxanes; curdlan, xanthan gum, dielan gum, hyaluronic acid, alkaline genus-producing polysaccharides such as polysaccharides, and one or more of these It is possible.
  • Oils include liquid paraffin, squalane, petrolatum, polyisobutylene, polybutene, Hydrocarbons such as paraffin wax, ceresin wax, microcrystalline wax, and Phytschatrops wax; fats and oils such as moscow, olive oil, castor oil, mink oil, and mash demian nut oil; montan wax, beeswax, carnau Waxes such as waxes, candelilla wax, gay wax; jojoba oil, cetyl isooctanoate, isopropyl myristate, isopropyl normitate, octyldodecyl myristate, glyceryl trioctanoate, diglyceryl disostearate, triisostearin Diglyceryl acid, glyceryl tribehenate, pentaerythritol ester of rosin acid, neopentyl glycol dioctanoate, cholesterol fatty acid
  • an agent for improving obesity is provided that is excellent in the effect of improving obesity.
  • This obesity-improving agent can be prepared by simple operations, and can be easily added to and blended with familiar products.
  • an extremely excellent effect is exhibited especially when blended with an external preparation for skin or a fragrance.
  • the present invention is extremely practical.
  • a body soap was prepared by the following preparation procedure.
  • Table 1 shows the body soap prescriptions.
  • ingredients 4 to 6 in Table 1 were uniformly mixed at 75 ° C. to obtain a mixture A.
  • components 7 to 9 are uniformly mixed and dissolved at 75 ° C., and added to and mixed with the mixture A to neutralize. After cooling the neutralized mixture, ingredients 1-3 and ingredients 10, 11 were collected to obtain a body soap.
  • Plant essential oil In the table, the plant essential oil is an Italian cypress essential oil. The essential oil was purchased from Bio prises (hereinafter the same).
  • a body soap was prepared by the following preparation procedure.
  • Table 2 shows the body soap prescriptions.
  • Palm oil fatty acid jetanolamide 3. 8
  • ⁇ -3-Carene was purchased from 11 (11 ⁇ 11 Chemical Company Inc. (hereinafter the same)
  • the plant essential oil is one of laurel essential oil, neroli essential oil, ginger essential oil, and coffee essential oil.
  • Laurel essential oil and neroli essential oil were purchased from Bio prises, Ginger essential oil was purchased from Ungerer, and coffee essential oil was purchased from Danisco (hereinafter the same).
  • Body jewel was prepared by the following procedure. Table 3 shows the prescriptions for Body Gier. (Body Jewel preparation procedure)
  • the plant essential oil is a cypress essential oil.
  • Body jewel was prepared by the following procedure. Table 4 shows the prescriptions for Body Gier. (Body Jewel preparation procedure)
  • ingredients 1 to 6 in Table 2 were uniformly mixed at 70 ° C. to obtain a mixture A. Thereafter, the same operation as in Example 3 was performed to obtain a body gel.
  • the plant essential oil is one of laurel essential oil, neroli essential oil, ginger essential oil, and coffee essential oil.
  • a bath essence was prepared by the following procedure. Table 5 shows the nose essence prescriptions.
  • the plant essential oil is a cypress essential oil.
  • Nose essence was prepared by the following procedure. Table 6 shows the prescriptions for luminescence. (Bath essence preparation procedure)
  • the plant essential oil is one of laurel essential oil, neroli essential oil, ginger essential oil, and coffee essential oil.
  • Index weight (kg) Z height 2 (m)) was conducted on obese students (20 students) who showed 25 or more .
  • the salivary cortisol reduction effect was explained to the subjects using the gamma-one-coated cortisol measurement kit by explaining the precautions (meal time, designated food and drink prohibited, saliva collection time, etc.) to each individual.
  • the saliva was collected. Put the absorbent cotton of the measurement kit in the mouth, and after 2-3 minutes (appropriately, the absorbent cotton is covered with saliva and lightly bites and oozes out).
  • the absorbent cotton is returned to the kit container, and after freezing, concentration analysis is performed.
  • the analysis method is the Radioimmune Assay (RIA), and the measuring instrument is the Autouel Gamma System AceuFLEX a 7010.
  • RIA Radioimmune Assay
  • the measuring instrument is the Autouel Gamma System AceuFLEX a 7010.
  • weight loss means both weight loss and body fat percentage reduction.
  • laurel essential oil did not show a significant weight loss effect, and neroli essential oil, ginger essential oil, and coffee essential oil tended to increase in both body weight and body fat percentage.
  • Cypress essential oil and ⁇ -3-carene also contributed to weight loss.
  • eau de toilette was prepared by a conventional method.
  • Example 9 Preparation of Body Lotion Containing Obesity Condition Improvement Agent Based on the following formulation examples, a body lotion was prepared by a conventional method.
  • Body milk was prepared by the following procedure. The formula for body milk is shown in Formulation Example 4.
  • an aroma oil was prepared by a conventional method.
  • room fredalance was prepared by a conventional method.
  • room fredalance was prepared by a conventional method.
  • the present invention also includes the invention described below.
  • Cypress essential oil and base power A composition essentially composed of a novel composition characterized by being able to improve obesity.
  • a novel composition characterized in that it is a composition essentially composed of ⁇ 3 -strength and a base and can improve obesity.
  • Cypress essential oil and base power It is a composition that is essentially composed, it can improve obesity, and the strength also has an antidepressant action and acupuncture or stress reduction action. New composition.
  • a composition consisting essentially of ⁇ 3 -strength and a base, which is capable of improving obesity and also has an antidepressant action and an acupuncture or stress reducing action.
  • New composition consisting essentially of ⁇ 3 -strength and a base, which is capable of improving obesity and also has an antidepressant action and an acupuncture or stress reducing action.
  • Cypress essential oil and base power A composition essentially composed of a novel composition characterized in that it can improve obesity and is useful as a skin external preparation or fragrance.
  • the new composition is stored so that it can freely come into contact with air, and through the air in the space where the new composition is stored, Cypress essential oil or ⁇ -3-calen from the new composition, Alternatively, a method for improving an obesity state, comprising incorporating a volatile component containing cypress essential oil or ⁇ 3 -strength into the body.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

[PROBLEMS] To provide an excellent agent for improving obesity conditions. To provide an excellent agent for improving obesity conditions which further has an antidepressant effect and/or a stress-relieving effect and can be easily prepared. [MEANS FOR SOLVING PROBLEMS] Cypress essential oil or δ-3-carene is used as the active ingredient for improving obesity conditions. It is advantageous to use the thus obtained agent for improving obesity conditions in an external skin preparation or a fragrance. It is also possible to volatilize a perfume, which contains cypress essential oil or δ-3-carene, in a human living space.

Description

肥満状態改善剤  Obesity improving agent
技術分野  Technical field
[0001] 本発明は、特定の精油又は合成香料からなる肥満状態改善剤およびそれを含有 する皮膚外用剤及び芳香剤に関する。  [0001] The present invention relates to an obesity improving agent comprising a specific essential oil or synthetic fragrance, and a skin external preparation and fragrance containing the same.
背景技術  Background art
[0002] 高カロリー食の摂取、運動不足等、近年の社会情勢の変化によるため力 肥満と呼 ばれる人の数は増加している。肥満は糖尿病、高血圧、動脈硬化などの各種生活習 慣病の温床であり、健康維持のためには肥満状態の改善が重要である。たとえば、 肥満状態の改善のために各種運動器具を使用する方法、ダイエット食品の採用、食 欲抑制剤などの療法などが知られているが、肥満状態を改善できたという報告はそう 多くはない。その理由は、いろいろとあるのであろうが、肥満を改善するために使用 する各種器具の購入や保管などが簡単ではな ヽこと、前記各種器具を使用できるよ うにする準備が簡単ではな 、こと、肥満状態を改善するために行った時間や努力に 対して、改善効果があつたと感じられる程度が少ないこと、肥満を改善するための行 動が、精神的な圧迫感を与えることになること、一度肥満状態となるとその肥満状態 力 抜け出すことはそう簡単ではないことなどの問題点があり、結局、肥満を改善しよ うとする意欲の低減化や、肥満を改善するための行動を長く続けることができなくなる こと、あるいは摂食中枢での刺激や所謂腹時計などの体の構造的な点などが考えら れる。  [0002] The number of people called “force obesity” is increasing due to recent changes in social conditions such as intake of high-calorie diet and lack of exercise. Obesity is a hotbed for various lifestyle-related diseases such as diabetes, hypertension, and arteriosclerosis, and improvement of obesity is important for maintaining health. For example, methods for using various exercise equipment to improve obesity, adoption of diet foods, and appetite suppressant therapy are known, but there are not many reports that they have improved obesity. . There may be various reasons for this, but it is not easy to purchase and store various instruments used to improve obesity, and it is not easy to prepare to use the instruments. The degree to which the improvement effect is less felt against the time and effort made to improve obesity, and the action to improve obesity gives a feeling of mental pressure Once you become obese, there is a problem that it is not so easy to get out of your obesity. Eventually, the desire to improve obesity will be reduced and actions to improve obesity will continue for a long time It may be impossible to do this, or stimulation at the feeding center and so-called abdominal clock, and other structural points of the body.
なお、本発明では肥満状態を、 BMI値( = Body  In the present invention, the obesity state is represented by the BMI value (= Body
Mass Index体重 (kg)Z身長2 (m))が 25以上である状態をいう。 Mass Index Weight (kg) Z Height 2 (m)) is 25 or more.
[0003] その点、いわゆる痩身剤を含有させた皮膚外用剤を人の肌に直接適用したり、瘦 身剤を含有する食品を摂取したり、痩身剤を含有させたボディソープにて体を清浄 する方法などは、精神的な圧迫感を与えるなどの問題点がなぐ有効な方法であると いうことができる。具体的な技術としては、例えば、コニャック油またはマテ油を皮膚 外用剤または食品に添加する方法 (特許文献 1)、グレープフルーツオイルからリモネ ンを 10〜: LOO質量%除去した改質グレープフルーツオイルをィ匕粧料や食品添加す る方法 (特許文献 2)などがある。しかし、これらの技術でも、肥満改善効果の点では 十分と 、うことができず、改善される余地が残されて 、る。 [0003] In this regard, a skin external preparation containing a so-called slimming agent is directly applied to human skin, a food containing a slimming agent is taken, and a body soap containing a slimming agent is used to treat the body. It can be said that the method of cleaning is an effective method that eliminates problems such as giving a feeling of mental pressure. Specific techniques include, for example, a method of adding cognac oil or mate oil to an external preparation for skin or food (Patent Document 1), from grapefruit oil to limonate. For example, there is a method of adding modified grapefruit oil from which LOO mass% is removed to a cosmetic or food (Patent Document 2). However, even with these techniques, the effect of improving obesity is not sufficient, leaving room for improvement.
また、特許文献 3には合成香料として知られているリモネン、ビネン、ミルセン、ベン ジルベンゾエートより選ばれる 1種又は 2種以上を痩身用香料として使用すると記載 されている。しかし、その文献はそれら香料を例示するだけであり、上記香料単独あ るいは上記香料の混合物自体を痩身用香料として実施例にぉ 、て確認して 、るの ではな!/、ので、前記香料は痩身香料として単に例示されて 、る程度のことに過ぎず、 痩身用香料としてどの程度有効であるのか不明である。  Patent Document 3 describes that one or more selected from limonene, vinylene, myrcene and benzylbenzoate, which are known as synthetic fragrances, are used as a fragrance for slimming. However, that document only exemplifies those fragrances, and the above fragrance alone or a mixture of the above fragrances itself is not used as a fragrance for slimming in the examples. The fragrance is merely exemplified as a slimming fragrance, and is only to the extent that it is unclear how effective it is as a slimming fragrance.
[0004] 一方、特許文献 4には、活性増強精油の一例としてサイプレス精油が記載されて!ヽ る。また、特許文献 5には、植物抽出エキスとしてハーブ抽出エキスを含有させた、リ ラックス効果を有するゼリー状の食品が開示され、ハーブ抽出エキスとしてサイプレス 精油が開示されているが、それら文献にはサイプレス精油が肥満改善効果を有する 効果があるとの記載はない。また、特許文献 6には、ラベンダー精油、ローズマリー精 油またはべルガモット精油、レモン精油又はライム精油、サイプレス精油またはジュ- パーべリー精油、及びキヤリヤーオイルカゝら構成される混合物が記載され、その混合 物は顔面部の余分な脂肪をすばやぐ徹底的に除去して顔面部の輪郭を改善する 効果があると記載されている。ところが、その混合物では、レモン精油、ローズマリー 精油、およびラベンダー精油には脂肪の除去を示唆する記載があるものの、サイプレ ス精油にそのような点を示唆する記載はない。 [0004] On the other hand, Patent Document 4 describes a cypress essential oil as an example of an activity-enhancing essential oil. Further, Patent Document 5 discloses a jelly-like food having a relaxed effect containing a herb extract as a plant extract, and Cypress essential oil is disclosed as a herb extract. There is no description that Cypress essential oil has an effect of improving obesity. Patent Document 6 describes a mixture comprising lavender essential oil, rosemary essential oil or bergamot essential oil, lemon essential oil or lime essential oil, cypress essential oil or juicer essential oil, and carrier oil. The mixture is described as having an effect of improving facial contours by quickly and thoroughly removing excess fat on the facial surface. However, in the mixture, lemon essential oil, rosemary essential oil, and lavender essential oil have been described to suggest fat removal, but cypress essential oil has no description to suggest such a point.
[0005] 特許文献 1 :特開 2005— 68176号公報 Patent Document 1: Japanese Patent Application Laid-Open No. 2005-68176
特許文献 2 :特開 2005— 194252号公報  Patent Document 2: JP-A-2005-194252
特許文献 3:特開 2002— 265977号公報  Patent Document 3: Japanese Patent Laid-Open No. 2002-265977
特許文献 4:特公平 7— 57734号公報  Patent Document 4: Japanese Patent Publication No. 7-57734
特許文献 5:特開 2003 - 245048号公報  Patent Document 5: Japanese Patent Laid-Open No. 2003-245048
特許文献 6 :中国特許公開第 1247735号  Patent Document 6: Chinese Patent Publication No. 1247735
発明の開示  Disclosure of the invention
発明が解決しょうとする課題 [0006] そこで、本発明の課題は優れた肥満状態改善剤を提供することにある。また、優れ た肥満状態改善剤であって、抗鬱作用及び Z又はストレス低減作用をも併せ持ち、 調製方法も簡単な肥満状態改善剤を提供することにある。 Problems to be solved by the invention [0006] Accordingly, an object of the present invention is to provide an excellent agent for improving obesity state. Another object of the present invention is to provide an agent for improving obesity status, which is an excellent agent for improving obesity status, which has both an antidepressant action and Z or stress reduction action, and is easy to prepare.
課題を解決するための手段  Means for solving the problem
[0007] 本発明者は上記課題を解決するために鋭意研究した結果、特定の精油に着目し、 その精油をボディソープに添加して使用してみたところ、意外にも優れた肥満状態改 善効果をもたらすとの知見を得た。また、肥満状態にある人にサイプレス精油を嗅が せると、抗鬱作用及び Z又はストレス低減作用により、食行動や睡眠行動並びに気 分障害等の生活習慣が改善される結果、肥満状態を改善する効果があるという知見 を得た。さらに研究を重ね δ—3—カレンにも同様な効果があるとの知見も得た。そ れらの知見に基づきさらに研究を重ね、遂に本発明を完成させた。  [0007] As a result of diligent research to solve the above problems, the present inventor has paid attention to a specific essential oil and added the essential oil to a body soap. The knowledge that it brings about an effect was acquired. In addition, when an obese person smells cypress essential oil, the anti-depressive action and Z or stress-reducing action improve lifestyle habits such as eating and sleeping behaviors and mood disorders, thereby improving obesity. The knowledge that it is effective was obtained. Through further research, we have found that δ-3-carene has the same effect. Based on these findings, further research was conducted and the present invention was finally completed.
[0008] すなわち、請求項 1の発明は、サイプレス精油からなることを特徴とする肥満状態改 善剤である。請求項 1の発明は、サイプレス精油を配合することを特徴とする肥満状 態改善剤でもある。さら〖こ、請求項 1の発明は、サイプレス精油を有効成分として含有 することを特徴とする肥満状態改善剤でもある。 [0008] That is, the invention of claim 1 is an obesity improving agent characterized by comprising a cypress essential oil. The invention of claim 1 is also an obesity improving agent characterized in that it contains cypress essential oil. Further, the invention of claim 1 is an obesity improving agent characterized by containing cypress essential oil as an active ingredient.
請求項 2の発明は、 δ 3—力レン力 なることを特徴とする肥満状態改善剤である 。また、請求項 2の発明は、 δ 3—力レンを配合することを特徴とする肥満状態改善 剤でもある。さらに、請求項 2の発明は、 δ 3—力レンを有効成分として含有するこ とを特徴とする肥満状態改善剤でもある。  The invention of claim 2 is an obesity-condition improving agent characterized by having a δ 3 -force force. The invention of claim 2 is also an obesity condition improving agent characterized by containing δ 3 -strength. Furthermore, the invention of claim 2 is an obesity condition improving agent characterized by containing δ 3 -strength as an active ingredient.
請求項 3の発明は、請求項 1又は 2の発明において、抗鬱作用及び Ζ又はストレス 低減作用をさらに有することを特徴とする。すなわち、上記肥満状態改善剤が、抗鬱 作用をさらに有することを特徴とし、上記肥満状態改善剤が、ストレス低減作用をさら に有することを特徴とし、上記肥満状態改善剤が、抗鬱作用及びストレス低減作用を さらに有することを特徴とする。請求項 3の発明は、請求項 1又は 2の発明において、 抗鬱作用及び Ζ又はストレス低減作用により肥満状態を改善することを特徴とする発 明でもある。  The invention of claim 3 is characterized in that in the invention of claim 1 or 2, it further has an antidepressant action and a wrinkle or stress reducing action. That is, the obesity condition-improving agent is further characterized by having an antidepressant action, the obesity condition-improving agent is further having a stress-reducing action, and the obesity condition-improving agent is characterized by an antidepressant action and It further has a stress reducing effect. The invention of claim 3 is also an invention characterized in that, in the invention of claim 1 or 2, the obesity state is improved by an antidepressant action and an epilepsy or stress reducing action.
請求項 4の発明は、請求項 1〜3記載のいずれかの肥満状態改善剤を含有するこ とを特徴とする皮膚外用剤であり、請求項 5発明は、請求項 1〜3記載のいずれかの 肥満状態改善剤を含有することを特徴とする芳香剤である。 The invention of claim 4 is an external preparation for skin containing the obesity condition-improving agent of any one of claims 1 to 3, and the invention of claim 5 is any of claims 1 to 3. The A fragrance comprising an obesity-condition improving agent.
請求項 6の発明は、肥満状態改善のための、サイプレス精油又は δ 3—力レンを 含む香料の使用方法の発明である。  The invention of claim 6 is an invention of a method of using a fragrance containing cypress essential oil or δ3-strength for improving obesity.
なお、本発明の肥満状態改善剤の機能の一つとして、肥満状態から肥満状態では なくなること、つまり現象的には痩身したことになるので、本発明の肥満状態改善剤を 痩身剤と表現することもできる。  As one of the functions of the obesity condition-improving agent of the present invention, the obesity condition disappears from the obesity condition, that is, the phenomenon is slimming. Therefore, the obesity condition-improving agent of the present invention is expressed as a slimming agent. You can also.
[0009] 以下、本発明を詳細に説明する。 Hereinafter, the present invention will be described in detail.
本発明でのサイプレス精油はすでに公知の精油であり、特にイタリアンサイプレス 精油が好ましい。イタリアンサイプレス精油はヒノキ科イトスギ属の榭木植物から常法 により調製できるが、市販品を購入してもよい。  The cypress essential oil in the present invention is a known essential oil, and an Italian cypress essential oil is particularly preferable. The Italian cypress essential oil can be prepared from a cypress plant of the genus Cypressaceae by a conventional method, but a commercially available product may be purchased.
本発明での δ 3—力レンはすでに公知の合成香料ィ匕合物であり、天然物から抽 出して得ることもできるし、また生化学的合成法や公知の化学的合成方法により得る こともできるが、市販品を購入してもよい。  The δ3-force len in the present invention is a known synthetic fragrance compound, and can be obtained by extraction from a natural product, or obtained by a biochemical synthesis method or a known chemical synthesis method. You can also purchase a commercial product.
[0010] 上記サイプレス精油又は δ 3—力レンを肥満状態改善剤とすることに本発明の特 徴がある。ここでの肥満状態改善とは、肥満の程度を減少させることを意味し、肥満 の程度を維持することも含む。したがって、上記肥満状態改善剤とは、肥満の程度を 減少させる性質'機能を有する剤であり、肥満の程度を維持する剤をも含む。 [0010] A feature of the present invention is that the above-mentioned Cypress essential oil or δ3-strength is used as an obesity improving agent. The improvement of obesity state here means reducing the degree of obesity, and also includes maintaining the degree of obesity. Therefore, the agent for improving obesity condition is an agent having the property 'function of reducing the degree of obesity and also includes an agent for maintaining the degree of obesity.
[ooii] 本発明の肥満状態改善剤は、さらに抗鬱作用及び Ζ又はストレス低減作用を有す る。抗鬱作用は本出願前力も広く知られており、いろいろな原因,理由カも鬱状態に おち 、つた人が、鬱とは 、えな 、状態に少しでも変化させる作用を 、う。  [ooii] The obesity condition-improving agent of the present invention further has an antidepressant action and an epilepsy or stress-reducing action. The antidepressant action is well known in the pre-application, and there are various causes and reasons for depression, and one person is able to change the condition as much as possible.
ストレス低減作用も本出願前力 広く知られており、例えば、近年の複雑な社会環 境の影響からストレスを蒙った人力 そのストレスを少しでも和らげる作用をいう。 本発明でいう肥満状態改善剤は、所期の目的を達成できる程度であれば、他の配 合剤を添加させてもよい。それら配合剤は後述する。  The stress reduction effect is also well known before the filing of this application. For example, it refers to the human power that has received stress due to the influence of the complex social environment in recent years. The agent for improving obesity condition in the present invention may be added with other binders as long as the intended purpose can be achieved. These compounding agents will be described later.
[0012] また、本発明の肥満状態改善剤は、皮膚用外用剤に含有していてもよい。このよう な皮膚外用剤は、乳液、クリーム、化粧水、美容液、パック、洗顔料、ボディーソープ 、メーキャップ料、浴用剤、フレグランス、シャンプー、ヘアートリートメント、ヘアースタ ィリング剤、養毛剤、育毛剤等の化粧料 (薬用化粧料を含む)、軟膏、貼付剤、パップ 剤、リニメント剤等の外用医薬品のいずれであってもよい。その皮膚外用剤に、本発 明の肥満状態改善剤を含有させる量は、皮膚外用剤の違いによって最適な範囲が 異なるので、一概に規定できないが、例えば、皮膚外用剤に対して 0. 1〜20重量% 含有することが好ましぐ 0. 1〜: L0重量%含有することがより好ましい。 [0012] The obesity condition-improving agent of the present invention may be contained in an external preparation for skin. Such external preparations for skin include emulsions, creams, lotions, cosmetics, packs, facial cleansers, body soaps, makeup agents, bath preparations, fragrances, shampoos, hair treatments, hair styling agents, hair nourishing agents, hair restorers, etc. (Including medicated cosmetics), ointments, patches, patches Any of external medicines such as pills and liniments may be used. The amount of the external preparation for skin to contain the agent for improving obesity condition of the present invention cannot be defined unconditionally because the optimal range differs depending on the external preparation for skin, but for example, 0.1% for external preparation for skin. It is preferable to contain ˜20% by weight. 0.1˜: It is more preferred to contain L0% by weight.
さらに、本発明の肥満状態改善剤は、歯磨き、洗口剤等のオーラルケア製品、食品 等〖こ含有させることもできる。肥満状態改善剤の配合量は特に制限されないが、例え ば、前記製品、食品等に対して 0. 1〜20重量%含有することが好ましぐ 0. 1〜10 重量%含有することがより好ましい。  Furthermore, the obesity condition-improving agent of the present invention can also be incorporated into oral care products such as toothpaste and mouthwash, foods and the like. The compounding amount of the obesity condition improving agent is not particularly limited. For example, it is preferable to contain 0.1 to 20% by weight with respect to the product, food, etc. 0.1 to 10% by weight is more preferable. preferable.
[0013] また、本発明の肥満状態改善剤は、そのままで又は他の成分とともに配合 '混合す ることにより、ルームフレグランス、カーフレグランス、ァロマキャンドル、ァロマオイル 等の芳香剤に含有させることができる。このような芳香剤に、本発明の肥満状態改善 剤を含有させる量は、芳香剤の違いによって最適な範囲が異なるので、一概に規定 できないが、例えば、芳香剤に対して 0. 5〜: L00重量 %含有させることが好ましい。  [0013] The obesity condition-improving agent of the present invention can be contained in a fragrance such as a room fragrance, a car fragrance, an aroma candle, an aroma oil, etc. as it is or by mixing and mixing with other ingredients. . The amount of the fragrance containing the agent for improving obesity condition of the present invention cannot be generally specified because the optimum range varies depending on the fragrance, but for example, 0.5 to: It is preferable to contain L00% by weight.
[0014] 本発明はサイプレス精油と基剤力 本質的に構成される肥満状態改善用組成物を 提供する。また、 δ 3—力レンと基剤から本質的に構成される肥満状態改善用組成 物を提供する。ここで基剤とは、サイプレス精油又は δ 3—力レンを担持することが できる物質を意味し、サイプレス精油又は δ 3—力レンを担持することができる物質 であればどのような物質も使用可能である。代表的な例として、アルコール類などの 各種溶媒、ワセリン等の各種油剤等が挙げられるが、これらに限定されない。  [0014] The present invention provides a composition for improving obesity which consists essentially of cypress essential oil and base power. Also provided is a composition for improving obesity which is essentially composed of δ 3 -strength and a base. Here, the base means a substance that can carry Cypress essential oil or δ 3 -strength, and any substance that can carry Cypress essential oil or δ 3 -strength is used. Is possible. Representative examples include, but are not limited to, various solvents such as alcohols and various oils such as petrolatum.
[0015] また本発明では、肥満状態改善のための、サイプレス精油又は δ 3—力レンを含 む香料の使用方法を提供する。このような使用方法としては、たとえば、肥満状態改 善のための、サイプレス精油又は δ 3—力レンを含む香料を人が生活する空間に 揮散させる方法等が挙げられる。人が生活する空間の例としては、執務室内の空間 、健康の保持'向上と、ときにより美容のためフィットネス空間、居室内や浴室内など の人の居住空間等が挙げられるが、それらに限定されない。前記方法は肥満状態改 善のための、サイプレス精油又は δ—3—カレンを含む香料の環境フレダランスとし ての使用ということもできる。前記揮散させる方法は、特に制限されないのであり、換 気装置内の所定部位に、サイプレス精油又は δ 3—力レンを含む香料を揮散させ 、空気と共に空間内に揮散させる方法、任意の香料揮散装置を空間内に配置し、サ ィプレス精油又は δ 3—力レンを含む香料を空間内に揮散する方法等が挙げられ る。 [0015] The present invention also provides a method of using a fragrance containing cypress essential oil or δ3-strength to improve obesity. Examples of such a method include a method of evaporating a fragrance containing cypress essential oil or δ 3 -strength in a space where a person lives to improve obesity. Examples of spaces in which people live include, but are not limited to, spaces in offices, health maintenance, and, in some cases, fitness spaces for beauty and living spaces such as in living rooms and bathrooms. Not. The method can also be said to be the use of cypress essential oils or fragrances containing δ-3-carene as an environmental flared lance to improve obesity. The method of volatilization is not particularly limited, and a fragrance containing Cypress essential oil or δ3-power lenght is volatilized at a predetermined site in the aeration apparatus. And a method of volatilizing in the space together with air, a method of arranging an arbitrary fragrance volatilization device in the space, and volatilizing perfume containing Cypress essential oil or δ 3 -power len in the space, and the like.
なお、肥満状態改善剤として、効果はサイプレス精油又は δ 3—力レンほどでは ないが、ペパーミント精油も肥満状態改善を持つことが判明した。  It was found that peppermint essential oil also has an improvement in obesity status, although it is not as effective as an obesity improvement agent as Cypress essential oil or δ 3 -strength.
[0016] 本発明でいう皮膚外用剤や芳香剤には、慣用の配合剤を添加しておいてもよい。 [0016] A conventional compounding agent may be added to the external preparation for skin or fragrance according to the present invention.
それら添加される配合剤としては、皮膚外用剤や外用医薬品の製剤に一般的に用 いられる、水 (精製水、温泉水、深層水、イオン交換水等)、溶媒 (アルコール類、多 価アルコール類等)界面活性剤、油剤、ゲル化剤、着色剤、水溶性高分子、皮膜形 成剤、榭脂、紫外線防御剤、酸化防止剤、防腐剤、香料、消臭剤、塩類、 ΡΗ調整剤 、清涼剤、動物,微生物由来抽出物、植物抽出物、血行促進剤、収斂剤、抗脂漏剤 、美白剤、抗炎症剤、活性酸素消去剤、細胞賦活剤、保湿剤、キレート剤、角質溶解 剤、酵素、ホルモン類、ビタミン類等が挙げられる。  These added ingredients include water (purified water, hot spring water, deep water, ion-exchanged water, etc.) and solvents (alcohols, polyhydric alcohols, etc.) that are commonly used in preparations for external preparations for skin and external medicine Etc.) Surfactant, oil agent, gelling agent, colorant, water-soluble polymer, film forming agent, grease, UV protection agent, antioxidant, preservative, fragrance, deodorant, salt, wrinkle adjustment Agent, freshener, animal, microbial extract, plant extract, blood circulation promoter, astringent agent, anti-seborrheic agent, whitening agent, anti-inflammatory agent, active oxygen scavenger, cell activator, moisturizer, chelating agent, Examples include keratolytic agents, enzymes, hormones, and vitamins.
[0017] 前記界面活性剤としては、ポリオキシエチレンモノステアリン酸グリセリル、ポリオキ シエチレンモノォレイン酸グリセリルなどのポリオキシエチレングリセリン脂肪酸エステ ル;モノミリスチン酸へキサグリセリル、モノラウリン酸デカグリセリル、モノステアリン酸 デカグリセリルなどのポリグリセリン脂肪酸エステル;ポリオキシエチレンモノミリスチン 酸ソルビタン、ポリオキシエチレンモノステアリン酸ソルビタン、ポリオキシエチレントリ ォレイン酸ソルビタンなどのポリオキシエチレンソルビタン脂肪酸エステル;ポリオキシ エチレン硬化ひまし油、ポリオキシエチレン硬化ひまし油などのポリオキシエチレン硬 化ひまし油;ポリオキシエチレンコレステリルエーテル、ポリオキシエチレンコレステリ ルエーテルなどのポリオキシエチレンコレステリルエーテル;ポリオキシエチレンフイト ステリルエーテル、ポリオキシエチレンフィトステリルエーテルなどのポリオキシェチレ ンフィトステリルエーテル;モノラウリン酸ポリオキシエチレングリコール、モノステアリン 酸ポリオキシエチレングリコールなどのポリエチレングリコール脂肪酸エステル;ポリオ キシエチレンラウリノレエ一テル、ポリオキシエチレンべへ-ノレエーテル、ポリオキシェ チレンセチルエーテル、ポリオキシエチレンステアリルエーテルなどのポリオキシェチ レンアルキルエーテル;ポリオキシエチレンポリオキシプロピレンセチルエーテル、ポ リオキシエチレンポリオキシプロピレンテトラデシルエーテルなどのポリオキシェチレ ンポリオキシプロピレンアルキルエーテル;ポリオキシエチレンノニルフエニルエーテ ル、ポリオキシエチレンォクチルフエニルエーテルなどのポリオキシエチレンアルキル フエ-ルエーテル;等が挙げられる。 [0017] Examples of the surfactant include polyoxyethylene glyceryl fatty acid esters such as polyoxyethylene monostearate glyceryl and polyoxyethylene monooleate glyceryl; monomyristate hexaglyceryl, monolaurate decaglyceryl, monostearate Polyglycerin fatty acid esters such as decaglyceryl acid; Polyoxyethylene monomyristate Polyoxyethylene sorbitan fatty acid esters such as sorbitan polyoxyethylene monostearate, sorbitan polyoxyethylene tristearate; Polyoxyethylene hydrogenated castor oil, polyoxyethylene Polyoxyethylene hardened castor oil such as hardened castor oil; polyoxyethylene cholesteryl ether, polyoxyethylene cholesteryl ether, etc. Polyoxyethylene cholesteryl ethers; polyoxyethylene phytosteryl ethers, polyoxyethylene phytosteryl ethers such as polyoxyethylene phytosteryl ethers; polyethylene glycol fatty acid esters such as polyoxyethylene glycol monolaurate and polyoxyethylene glycol monostearate; Polyoxyethylene alkyl ethers such as polyoxyethylene lauryl ether, polyoxyethylene benoyl ether, polyoxyethylene cetyl ether, polyoxyethylene stearyl ether; polyoxyethylene polyoxypropylene cetyl ether, polyethylene Examples include polyoxyethylene polyoxypropylene alkyl ethers such as reoxyethylene polyoxypropylene tetradecyl ether; polyoxyethylene alkyl ethers such as polyoxyethylene nonyl phenyl ether and polyoxyethylene octyl phenyl ether; .
また、ラウリン酸ナトリウム、ミリスチン酸ナトリウム、パルミチン酸ナトリウムなどの脂肪 酸塩;ポリオキシエチレンラウリルエーテルリン酸ナトリウム、ポリオキシエチレンセチ ルエーテルリン酸ナトリウム、ジポリオキシエチレンセチルエーテルリン酸ナトリウムな どのポリオキシエチレンアルキルエーテルリン酸塩;ココイルメチルタウリンナトリウム、 ステアロイルメチルタウリンナトリウムなどのァシルタウリン塩;ラウリル硫酸ナトリウム、 セチル硫酸ナトリウムなどのアルキル硫酸塩;ポリオキシエチレンラウリルエーテル硫 酸ナトリウム、ポリオキシエチレンノユルフェ-ルエーテル硫酸ナトリウムなどのポリオ キシエチレンアルキルエーテル硫酸塩等を挙げられる。これらを一種又は二種以上 用!/、ることができる。  Also, fatty acid salts such as sodium laurate, sodium myristate, and sodium palmitate; polyoxyethylene such as sodium polyoxyethylene lauryl ether, sodium polyoxyethylene cetyl ether, sodium dipolyoxyethylene cetyl ether phosphate Ethyl alkyl ether phosphates; Acyl taurine salts such as sodium cocoyl methyl taurate and sodium stearoyl methyl taurate; Alkyl sulfates such as sodium lauryl sulfate and sodium cetyl sulfate; Sodium polyoxyethylene lauryl ether sulfate, Polyoxyethylene urea ether Examples thereof include polyoxyethylene alkyl ether sulfates such as sodium sulfate. You can use one or more of these!
ここで、ポリオキシエチレンユニットは、 3〜60程度である。  Here, a polyoxyethylene unit is about 3-60.
[0018] 高分子化合物としては、アラビアガム、キサンタンガム、タラガム、ガッティガム、カラ ギーナン、カラャガム、グァーガム、タマリンド種子ガム、メチルセルロース、ヒドロキシ メチノレセノレロース、ヒドロキシェチルセルロース、ポリビニルアルコール、ヒドロキシプ 口ピルセルロース、カルボキシメチルセルロース等;(メタ)アクリル酸'(メタ)アクリル酸 アルキル共重合体、(メタ)アクリル酸アルキル.スチレン共重合体、ポリ酢酸ビュル、 ビュルピロリドン.スチレン共重合体、アクリル—シリコーン共重合体、トリメチルシロキ シケィ酸の重合体;カードラン、キサンタンガム、ジエランガム、ヒアルロン酸、アルカリ ゲネス菌産生多糖体などの微生物産生多糖類が挙げられ、これらより一種又は二種 以上を用いることができる。 [0018] Examples of the high molecular weight compound include gum arabic, xanthan gum, tara gum, gati gum, carrageenan, cara gum, guar gum, tamarind seed gum, methyl cellulose, hydroxy methenoresenolellose, hydroxy ethyl cellulose, polyvinyl alcohol, hydroxy pour cellulose , Carboxymethyl cellulose, etc .; (meth) acrylic acid '(meth) acrylic acid alkyl copolymer, (meth) acrylic acid alkyl. Styrene copolymer, poly (acetate butyl), butylpyrrolidone. Styrene copolymer, acrylic-silicone copolymer Polymers of polymers, trimethylsiloxanes; curdlan, xanthan gum, dielan gum, hyaluronic acid, alkaline genus-producing polysaccharides such as polysaccharides, and one or more of these It is possible.
[0019] 着色剤として、酸化チタン、黒酸化チタン、コンジヨウ、群青、ベンガラ、黄酸化鉄、 黒酸化鉄、酸化亜鉛、酸ィ匕アルミニウム、酸化マグネシウム、酸ィ匕ジルコニウム、炭酸 マグネシウム、炭酸カルシウム、硫酸バリウム、酸化クロム、水酸化クロム、カーボンブ ラック、タール系色素等が挙げられる。  [0019] As a colorant, titanium oxide, black titanium oxide, konjiio, ultramarine blue, bengara, yellow iron oxide, black iron oxide, zinc oxide, acid-aluminum, magnesium oxide, acid-zirconium, magnesium carbonate, calcium carbonate, Examples thereof include barium sulfate, chromium oxide, chromium hydroxide, carbon black, and tar dyes.
[0020] 油剤としては、流動パラフィン、スクヮラン、ワセリン、ポリイソブチレン、ポリブテン、 パラフィンワックス、セレシンワックス、マイクロクリスタリンワックス、フイツシャトロプスヮ ックス等の炭化水素類;モクロウ、ォリーブ油、ヒマシ油、ミンク油、マ力デミアンナッツ 油等の油脂類;モンタンワックス、ミツロウ、カルナゥバワックス、キャンデリラワックス、 ゲイロウ等のロウ類;ホホバ油、セチルイソォクタネート、ミリスチン酸イソプロピル、ノ ルミチン酸イソプロピル、ミリスチン酸オタチルドデシル、トリオクタン酸グリセリル、ジィ ソステアリン酸ジグリセリル、トリイソステアリン酸ジグリセリル、トリべヘン酸グリセリル、 ロジン酸ペンタエリトリットエステル、ジオクタン酸ネオペンチルグリコール、コレステロ ール脂肪酸エステル、 N -ラウロイル -L-グルタミン酸ジ(コレステリル ·ベへ-ル · オタチルドデシル)等のエステル類;ステアリン酸、ラウリン酸、ミリスチン酸、ベへニン 酸、イソステアリン酸、ォレイン酸、 12—ヒドロキシステアリン酸等の脂肪酸類;ステアリ ノレアノレコーノレ、セチルアルコール、ラウリルアルコール、ォレイルアルコール、やノス テアリルアルコール、ベへ-ルアルコール等の高級アルコール類;スフインゴシン類; セラミド類;擬似セラミド類;低重合度ジメチルポリシロキサン、高重合度ジメチルポリ シロキサン、メチルフエ二ルポリシロキサン、デカメチルシクロペンタシロキサン、ォクタ メチルシクロテトラシロキサン、フッ素変性シリコーン等のシリコーン類;パーフルォロ ポリエーテル、パーフルォロデカン、パーフルォロオクタン等のフッ素系油剤類;ラノリ ン、酢酸ラノリン、ラノリン脂肪酸イソプロピル、ラノリンアルコール等のラノリン誘導体 類;等が挙げられ、これらを一種又は二種以上用いることができる。 [0020] Oils include liquid paraffin, squalane, petrolatum, polyisobutylene, polybutene, Hydrocarbons such as paraffin wax, ceresin wax, microcrystalline wax, and Phytschatrops wax; fats and oils such as moscow, olive oil, castor oil, mink oil, and mash demian nut oil; montan wax, beeswax, carnau Waxes such as waxes, candelilla wax, gay wax; jojoba oil, cetyl isooctanoate, isopropyl myristate, isopropyl normitate, octyldodecyl myristate, glyceryl trioctanoate, diglyceryl disostearate, triisostearin Diglyceryl acid, glyceryl tribehenate, pentaerythritol ester of rosin acid, neopentyl glycol dioctanoate, cholesterol fatty acid ester, N-lauroyl-L-di-glutamic acid (cholesteryl Esters such as steatilic acid, lauric acid, myristic acid, behenic acid, isostearic acid, oleic acid, 12-hydroxystearic acid; stearino-leanolenoleole, cetyl alcohol, lauryl alcohol, Higher alcohols such as rail alcohol, nostearyl alcohol, and beryl alcohol; Sphingosines; Ceramides; Pseudoceramides; Low polymerization dimethylpolysiloxane, High polymerization dimethylpolysiloxane, Methylphenylpolysiloxane, Silicones such as decamethylcyclopentasiloxane, octamethylcyclotetrasiloxane, and fluorine-modified silicones; fluorinated oils such as perfluoropolyether, perfluorodecane, and perfluorooctane; lanolin, lanolin acetate, Phosphorus fatty isopropyl, lanolin derivatives such as lanolin alcohols; and the like, and these can be used singly or in combination.
発明の効果  The invention's effect
[0021] 本発明により、肥満状態の改善効果が優れた肥満状態改善剤が提供される。この 肥満状態改善剤は簡単な操作で調製可能であり、身近な製品に添加 ·配合すること も容易であり、生活の一部に取り入れやすいという特徴もある。しかも皮膚への感作 性も殆どないので、とくに皮膚外用剤や芳香剤などに配合すると、極めて優れた効果 が発揮される。本発明は極めて実用的なものである。  [0021] According to the present invention, an agent for improving obesity is provided that is excellent in the effect of improving obesity. This obesity-improving agent can be prepared by simple operations, and can be easily added to and blended with familiar products. In addition, since there is almost no sensitization to the skin, an extremely excellent effect is exhibited especially when blended with an external preparation for skin or a fragrance. The present invention is extremely practical.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0022] 以下、実施例に基づき本発明を詳細に説明するが、本発明はこれら実施例になん ら限定されるものではない。なお、以下の数値はとくに断らないかぎり、重量部あるい は重量%である。 [0023] 実施例 1 肥満状態改善剤含有ボディソープの調製 [0022] Hereinafter, the present invention will be described in detail based on examples, but the present invention is not limited to these examples. The following numerical values are parts by weight or% by weight unless otherwise specified. Example 1 Preparation of Body Soap Containing Obesity Condition Improvement Agent
ボディソープを下記調製手順により調製した。ボディソープの処方は表 1のとおりで ある。  A body soap was prepared by the following preparation procedure. Table 1 shows the body soap prescriptions.
(ボディソープの調製手順)  (Body soap preparation procedure)
最初に表 1の成分 4〜6を 75°Cで均一に混合し、混合物 Aを得た。次に、成分 7〜9 を 75°Cで均一に混合溶解し、混合物 Aに添加混合して中和する。中和した混合物を 冷却後、成分 1〜3、成分 10、 11をカ卩え、ボディソープを得た。  First, ingredients 4 to 6 in Table 1 were uniformly mixed at 75 ° C. to obtain a mixture A. Next, components 7 to 9 are uniformly mixed and dissolved at 75 ° C., and added to and mixed with the mixture A to neutralize. After cooling the neutralized mixture, ingredients 1-3 and ingredients 10, 11 were collected to obtain a body soap.
[0024]
Figure imgf000010_0001
[0024]
Figure imgf000010_0001
1 , ジステアリン酸エチレングリコール  1, ethylene glycol distearate
2 . ヤシ油脂肪酸ジ タノ一ルァミド  2. Palm oil fatty acid ditanolamide
3 . ラウリルジメチルァミノ酢酸ぺタイ^  3. Lauryldimethylaminoacetic acid petite ^
4 . 水酸化カリウム  4. Potassium hydroxide
5 . デト酸ニナトリウム  5. Disodium detoate
6 . 精製水  6 Purified water
7 . ラウリン酸  7. Lauric acid
S . チン酸  S. Tinic acid
9 . チン酸  9. Tinic acid
0 . 防腐剤  0. Preservatives
1 . 植物精油
Figure imgf000010_0002
表中、植物精油は、イタリアンサイプレス精油である。なお、前記精油は Biolandes 社より購入した (以下、同様)。
1. Plant essential oil
Figure imgf000010_0002
In the table, the plant essential oil is an Italian cypress essential oil. The essential oil was purchased from Biolandes (hereinafter the same).
[0025] 実施例 2 肥満状態改善剤含有ボディソープの調製 Example 2 Preparation of a body soap containing an obesity-condition improving agent
ボディソープを下記調製手順により調製した。ボディソープの処方は表 2のとおりで ある。  A body soap was prepared by the following preparation procedure. Table 2 shows the body soap prescriptions.
(ボディソープの調製手順)  (Body soap preparation procedure)
最初に表 2の成分 4〜6を 75°Cで均一に混合し、混合物 Aを得た。これ以降は、実 施例 1と同様な操作を行 ヽ、ボディソープを得た。 [0026] 表 2 First, ingredients 4 to 6 in Table 2 were uniformly mixed at 75 ° C. to obtain a mixture A. Thereafter, the same operation as in Example 1 was performed, and a body soap was obtained. [0026] Table 2
ボディソ  Bodiso
(成分)  (Ingredient)
1. ジステアリン酸エチレングリコール 0. 8  1. Ethylene glycol distearate 0.8
2. ヤシ油脂肪酸ジェタノールァミ ド 3. 8  2. Palm oil fatty acid jetanolamide 3. 8
3. ラウリルジメチルァミノ酢酸べタイン 1. 2  3. Lauryldimethylaminoacetate betaine 1.2
4. 水酸化カリウム 4. 8  4. Potassium hydroxide 4.8
5. ェデト酸ニナトリウム 0. 1  5. Disodium edetate 0.1
6. 精製水 残量  6. Purified water remaining
7. ラウリン酸 5. 4  7. Lauric acid 5.4
8. ミリスチン酸 9. 0  8. Myristic acid 9.0
9. パルミチン酸 3. 6  9. Palmitic acid 3.6
0. 防腐剤 適量  0. Preservative appropriate amount
1. δ— 3—力レン 0. 8  1. δ— 3—Power Len 0.8
なお、 δ—3—カレンは 1(11^11 Chemical Company Inc.より購入した(以下、同様) Δ-3-Carene was purchased from 11 (11 ^ 11 Chemical Company Inc. (hereinafter the same)
[0027] 比較例 1 ボディソープの調製 [0027] Comparative Example 1 Preparation of body soap
実施例 1と同様な操作を行い、ボディソープを得た。ただし、植物精油は、ローレル 精油、ネロリ精油、ジンジャー精油、コーヒー精油のいずれかである。なお、ローレル 精油、およびネロリ精油は Biolandes 社より購入し、ジンジャー精油は Ungerer社より 購入し、コーヒー精油は Danisco社より購入した (以下、同様)。  The same operation as in Example 1 was performed to obtain a body soap. However, the plant essential oil is one of laurel essential oil, neroli essential oil, ginger essential oil, and coffee essential oil. Laurel essential oil and neroli essential oil were purchased from Biolandes, Ginger essential oil was purchased from Ungerer, and coffee essential oil was purchased from Danisco (hereinafter the same).
[0028] 実施例 3 肥満状態改善剤含有ボディジエルの調製 Example 3 Preparation of Body Giel Containing Obesity Condition Improvement Agent
ボディジエルを下記手順により調製した。ボディジエルの処方は表 3のとおりである。 (ボディジエルの調製手順)  Body jewel was prepared by the following procedure. Table 3 shows the prescriptions for Body Gier. (Body Jewel preparation procedure)
最初に表 3の成分 1〜6を 70°Cで均一に混合し、混合物 Aを得た。成分 7〜8を 70 °Cで均一に混合溶解し、混合物 Aに添加して乳化する。この乳化物を冷却しながら、 成分 9、成分 10〜 12を添カ卩して均一に混合し、ボディジエルを得た。 [0029] 表 3 First, components 1 to 6 in Table 3 were uniformly mixed at 70 ° C. to obtain a mixture A. Ingredients 7-8 are uniformly mixed and dissolved at 70 ° C, and added to mixture A to emulsify. While cooling this emulsion, ingredients 9 and 10-12 were added and mixed uniformly to obtain a body jewel. [0029] Table 3
ボディジエル  Body jewel
(成分) (%) (Ingredient) (%)
1. ステアリン酸 0. 51. Stearic acid 0.5
2. モノォレイン酸ポリオキシエチレンソルビタン 0. 52. Polyoxyethylene sorbitan monooleate 0.5
3. セ トステアリルアルコール 、 0. 5 4. 流動パラフィン 2. 〇3. cetostearyl alcohol, 0.5 4. liquid paraffin 2.
5. メチノレポリシロキサン 3. 05. Methylenopolysiloxane 3.0
6 , ジプロピレングリコール 10. 06, dipropylene glycol 10.0
7. トリエタノールァミン 0. 4 8. 精製水 残量 9. アタリル酸メタクリル酸共重合体 1 %水溶液 (注 1 ) 20. 07. Triethanolamine 0.4 4 8. Purified water Remaining 9. Atalyl methacrylic acid copolymer 1% aqueous solution (Note 1) 20. 0
10. ェタノ一ノレ 7. 010. Etano 1 7.0
1 1. 防腐剤 適量 1 2. 植物精油 0. 3 1 1. Preservative appropriate amount 1 2. Plant essential oil 0. 3
(注 1)カーボポール 1342 (Goodrich社製) (Note 1) Carbopole 1342 (Goodrich)
表中、植物精油は、サイプレス精油である。  In the table, the plant essential oil is a cypress essential oil.
[0030] 実施例 4 肥満状態改善剤含有ボディジエルの調製 Example 4 Preparation of body jewel containing an obesity condition-improving agent
ボディジエルを下記手順により調製した。ボディジエルの処方は表 4のとおりである。 (ボディジエルの調製手順)  Body jewel was prepared by the following procedure. Table 4 shows the prescriptions for Body Gier. (Body Jewel preparation procedure)
最初に表 2の成分 1〜6を 70°Cで均一に混合し、混合物 Aを得た。これ以降は、実施 例 3と同様な操作を行 ヽ、ボディジ ルを得た。 First, ingredients 1 to 6 in Table 2 were uniformly mixed at 70 ° C. to obtain a mixture A. Thereafter, the same operation as in Example 3 was performed to obtain a body gel.
[0031] 表 4 [0031] Table 4
ボディジエル  Body jewel
(成分) (%)  (Ingredient) (%)
1. ステアリン酸 0. 5  1. Stearic acid 0.5
2. モノォレイン酸ポリオキシエチレンソルビタン . 0. 5  2. Polyoxyethylene sorbitan monooleate. 0.5
3. セトステアリルァノレコーノレ 0. 5  3. Setostearylanolo Cornole 0.5
4. 流動パラフィン 2. 0  4. Liquid paraffin 2. 0
5. メチルポリシロキサン 3. 0  5. Methylpolysiloxane 3.0
6. ジブロピレンダリコール 10. 0  6. Dibropyrender Recall 10.0
7. トリエタノールァミン 0. 4  7. Triethanolamine 0.4
8. 精製水 残量  8. Remaining amount of purified water
9. アクリル酸メタクリル酸共重合体 1 %水溶液 (注 1 ) 20. 0  9. 1% aqueous solution of acrylic acid / methacrylic acid copolymer (Note 1) 20. 0
1 0. エタノール 7. 0  1 0. Ethanol 7.0
1 1. 防腐剤 適量  1 1. Preservative appropriate amount
1 2. δ _ 3—カレン 0. 3  1 2.δ_3—Karen 0.3
(注 1)カーボポール 1342 (Goodrich社製) (Note 1) Carbopole 1342 (Goodrich)
[0032] 比較例 2 ボディジヱルの調製 [0032] Comparative Example 2 Preparation of body gel
実施例 3と同様な操作を行い、ボディジエルを得た。ただし、植物精油は、ローレル 精油、ネロリ精油、ジンジャー精油、コーヒー精油のいずれかである。  The same operation as in Example 3 was performed to obtain a body jewel. However, the plant essential oil is one of laurel essential oil, neroli essential oil, ginger essential oil, and coffee essential oil.
[0033] 実施例 5 肥満状態改善剤含有バスエッセンスの調製 Example 5 Preparation of bath essence containing an obesity condition-improving agent
バスエッセンスを下記手順により調製した。ノ スエッセンスの処方は表 5のとおりであ る。  A bath essence was prepared by the following procedure. Table 5 shows the nose essence prescriptions.
(バスエッセンスの調製手順)  (Bath essence preparation procedure)
成分 1〜5を均一に混合し、バスエッセンスを得た。 Ingredients 1 to 5 were mixed uniformly to obtain a bath essence.
[0034] 表 5 [0034] Table 5
バスエッセンス  Bath essence
(成分) (%)  (Ingredient) (%)
1. 流動パラフィン 68. 5  1. Liquid paraffin 68.5
2. トリ 2 -ェチルへキサン酸グリセリル 15. 0  2. Glyceryl tri-2-ethylhexylate 15. 0
3. テトラオレイン酸ポリオキシェ y 卜 7. 0  3. Tetraoleic acid polyoxye y 卜 7.0
4. ポリオキシエチレンォレイルェ一テル 4. 5  4. Polyoxyethylene oil ether 4.5
5. 植物精油 5. 0  5. Plant essential oil 5.0
表中、植物精油は、サイプレス精油である。 In the table, the plant essential oil is a cypress essential oil.
実施例 6 肥満状態改善剤含有バスエッセンスの調製  Example 6 Preparation of a bath essence containing an obesity-improving agent
ノ スエッセンスを下記手順により調製した。バ ^ッセンスの処方は表 6のとおりである。 (バスエッセンスの調製手順)  Nose essence was prepared by the following procedure. Table 6 shows the prescriptions for luminescence. (Bath essence preparation procedure)
成分 1〜5を均一に混合し、バスエッセンスを得た。  Ingredients 1 to 5 were mixed uniformly to obtain a bath essence.
[0036]  [0036]
表 6  Table 6
(成分) (%) 流動パラフィン 68. 5 トリ 2 ェチルへキサン酸ダリセリル 1 5. 0 テトラオレィン酸ポリオキシエチレンソルビッ 卜 7. 0 ポリオキシエチレン才レイノレエ一テノレ 4. 5 δ— 3—力レン 6. 0 (Ingredients) (%) Liquid paraffin 68.5 Dariceryl triethyl hexylate 1 5. 0 Polyoxyethylene sorbitol tetraoleate 卜 7.0 Polyenoethylene-based Reynoleetenoret 4.5 5 δ-3—Strength 6 . 0
[0037] 比較例 3 バスエッセンスの調製 [0037] Comparative Example 3 Preparation of bath essence
実施例 5と同様な操作を行い、ノ スエッセンスを得た。ただし、植物精油は、ローレ ル精油、ネロリ精油、ジンジャー精油、コーヒー精油のいずれかである。  The same operation as in Example 5 was performed to obtain a no essence. However, the plant essential oil is one of laurel essential oil, neroli essential oil, ginger essential oil, and coffee essential oil.
[0038] 試験例 1 [0038] Test Example 1
試験は ΒΜΙ値( = Body Mass  Test is ΒΜΙ (= Body Mass
Index体重 (kg)Z身長2 (m))が 25以上を示す肥満学生(20名)を対象にして行なった 。まずコントロール期として、実施例及び比較例で示したィ匕粧品などを使用せずに、 2 週間をすごしてもら!ヽ (肥満状態改善剤非介入期)、肥満状態改善剤非介入期後に 身体測定 (体重、体脂肪率)、唾液コルチゾール測定 (ストレス尺度)、 GHQ、 SDS ( 抑鬱尺度)問診を行なった。 Index weight (kg) Z height 2 (m)) was conducted on obese students (20 students) who showed 25 or more . First, as a control period, you can spend 2 weeks without using the cosmetics shown in the examples and comparative examples!ヽ (obesity condition-improving agent non-intervention phase), obesity-conditioning agent non-intervention period, physical examination (body weight, body fat percentage), salivary cortisol measurement (stress scale), GHQ, SDS (depression scale) were conducted.
次に被験者 20名を 5グループに分け(1グループ: 4名)、各グループに実施例及 び比較例で示した 5種の精油のうち 1種を賦香したボディソープ、ボディジエルおよび ノ スエッセンスを 2週間使用してもらい (肥満状態改善剤介入期)、肥満状態改善剤 介入期後に身体測定 (体重、体脂肪率)、唾液コルチゾール測定 (ストレス尺度)、 G HQ、 SDS (抑鬱尺度)問診を行なった。  Next, 20 subjects were divided into 5 groups (1 group: 4 people), and body soap, body jewel, and nose essence were added to each group with one of the 5 essential oils shown in the examples and comparative examples. For 2 weeks (obesity condition improving agent intervention phase), obesity condition improving agent physical measurement (body weight, body fat percentage), salivary cortisol measurement (stress scale), G HQ, SDS (depression scale) after the intervention period Was done.
その結果を表 7に示す。  The results are shown in Table 7.
表 7 実施例 比較例 1〜 4 Table 7 Examples Comparative Examples 1-4
サイプレ δ - 3 - 口 一 レ ネロリ ジ ン ジ コ ー ヒ  Cypress δ-3-Kuchiichi Renello Resin Coffee
精油 力 精油 精油 精 一精油  Essential oil essential oil essential oil essential oil
 Oil
体重減少効果 〇 〇 Δ  Weight loss effect ○ ○ Δ
体脂肪率減少効果 〇 〇 Δ  Body fat percentage reduction effect ○ ○ Δ
唾液コルチゾール減少効果 〇 〇 ―  Salivary cortisol reduction effect ○ ○ ―
G H Q問診総合結果 〇 〇 △ 〇  G H Q Interview comprehensive results 〇 〇 △ 〇
G H Q問診結果 (不安と気分改善) 〇 〇 Δ 〇  G H Q Interview Results (Anxiety and mood improvement) ○ ○ Δ ○
GH Q問診結果 (睡眠障害) 〇 〇 〇 Δ  GH Q Questionnaire Result (Sleep Disorder) ○ ○ ○ Δ
S D S問診結果 〇 〇 ― ― SDS interview results ○ ○ ― ―
[0040] 表中、 体重減少効果 〇 平均体重 lkg以上減少 [0040] In the table, body weight loss effect 〇 Average body weight lkg or more decreased
Δ 平均体重 0〜: Lkg未満減少  Δ Average weight 0 ~: Less than Lkg
X 平均体重増加  X Average weight gain
体脂肪率減少渤果 〇 平均体脂肪率 2%以上減少  Decrease in body fat percentage 〇 Decrease in average body fat percentage by 2% or more
Δ 平均体脂肪率 0〜2%未満減少  Δ Average body fat percentage decreased by less than 0-2%
X 平均体脂肪率増加  X Increased average body fat percentage
唾液コルチゾ一ル減少効果 〇 平均コルチゾ一ル濃度 20以上減少  Salivary cortisol reduction effect 〇 Average cortisol concentration decreased by 20 or more
Δ 平均コルチゾール濃度 0~20減少  Δ Average cortisol concentration 0 ~ 20 decrease
X 平均コルチゾール濃度増加  X Increased mean cortisol concentration
G H Q問診総合結果 〇 GHQポイント 7以上減少  G H Q interview comprehensive result 〇 Decreased by 7 or more GHQ points
△ GHQポイント 以上減少  △ Decreased by more than GHQ points
X GHQポイント増加  X GHQ point increase
G H Q問診結果 (不安と気分改善) 〇 GHQポイント 4以上減少  G H Q interview results (anxiety and mood improvement) 〇 Decreased by 4 or more GHQ points
Δ GHQポィント 0~3以上減少  Δ GHQ point 0 ~ 3 or more decrease
X GHQポイント増加  X GHQ point increase
G H Q問診結果 (睡眠障害) 〇 GHQポイント 4以上減少  G H Q interview results (sleep disorders) 〇 Decreased by 4 or more GHQ points
Δ GHQボイント 0〜3以上減少  Δ GHQ Boyt 0 ~ 3 or more decrease
X GHQポイント増加  X GHQ point increase
S D S問診結果 〇 SDSポイント 5以上減少  S D S Interview Result 〇 Decrease SDS point by 5 or more
Δ SDS ボイント 0~4以上減少  Δ SDS Boyd 0 ~ 4 or more decrease
X SDS ポイント増加 表中、体脂肪率減少効果は、 TANITA BODY FAT ANALYZER TBF- 110 を用 いて測定した。  X SDS points increase In the table, body fat percentage reduction effect was measured using TANITA BODY FAT ANALYZER TBF-110.
[0041] 唾液コルチゾール減少効果は、ガンマ一'コート コルチゾール測定キットを用いた 被験者には、測定における注意事項 (食事時間や、飲食禁止指定食品、唾液の採 取時間など)を説明し、各自にて唾液の採取を実施した。測定キットの脱脂綿を口に 含み、 2〜3分後 (脱脂綿が唾液でひたひたになり、軽くかむとしみだす程度)脱脂綿 をキット容器にもどし、冷凍保存後、濃度分析を行なった。分析方法はラジオィムノア ッセィ法 (RIA)、測定機器はオートゥエルガンマシステム AceuFLEX a 7010を用い [0042] GHQ問診結果は以下の参考文献に従 、行なった。 [0041] The salivary cortisol reduction effect was explained to the subjects using the gamma-one-coated cortisol measurement kit by explaining the precautions (meal time, designated food and drink prohibited, saliva collection time, etc.) to each individual. The saliva was collected. Put the absorbent cotton of the measurement kit in the mouth, and after 2-3 minutes (appropriately, the absorbent cotton is covered with saliva and lightly bites and oozes out). The absorbent cotton is returned to the kit container, and after freezing, concentration analysis is performed. The analysis method is the Radioimmune Assay (RIA), and the measuring instrument is the Autouel Gamma System AceuFLEX a 7010. [0042] The results of GHQ interviews were conducted according to the following references.
参考文献 中川泰彬、大坊郁夫(日本版著) 1985 日本版 GHQ精神健康調査票 手引 日本文化科学社  Reference Yasutoshi Nakagawa, Ikuo Daibo (Japanese version) 1985 Japanese version GHQ Mental Health Questionnaire Guidance
SDS問診結果は以下の参考文献に従い行なった。  The results of SDS inquiry were conducted according to the following references.
参考文献 福田一彦、小林茂雄(日本版著) 1983 日本版 SDS精神健康調査票 使用の手引 日本文化科学社  References Kazuhiko Fukuda, Shigeo Kobayashi (Japanese version) 1983 Japanese version SDS mental health questionnaire usage guide Japan Cultural Science
[0043] 表 7に示されるように、サイプレス精油及び δ 3—力レンの減量効果が特に高いこ とが認められた。なお、ここでの減量は体重減少と体脂肪率減少の両方を意味する。 また、ローレル精油には顕著な減量効果は認められず、ネロリ精油、ジンジャー精油 、コーヒー精油は体重、体脂肪率とも上昇する傾向にあった。さらにサイプレス精油 及び δ—3—カレンは減量を引き起こすことが分力つた。  [0043] As shown in Table 7, it was recognized that the weight reduction effect of cypress essential oil and δ3-force len was particularly high. Note that weight loss here means both weight loss and body fat percentage reduction. In addition, laurel essential oil did not show a significant weight loss effect, and neroli essential oil, ginger essential oil, and coffee essential oil tended to increase in both body weight and body fat percentage. Cypress essential oil and δ-3-carene also contributed to weight loss.
[0044] 実施例 7 肥満状態改善剤含有フレッシュコロンの調製  Example 7 Preparation of Fresh Colon Containing Obesity Condition Improvement Agent
以下の処方に基づき、常法により、フレッシュコロンを調製した。  Based on the following formulation, a fresh colon was prepared by a conventional method.
処方例 1:フレッシュコロン  Formulation Example 1: Fresh Colon
(成分) (%) (Ingredient) (%)
1 . ェタノ一ル 9 0 . 01 Ethanol 9 0. 0
2 . 精製水 7 . 02 Purified water 7.0
3 . サイプレス精油 3 . 0 3. Cypress Essential Oil 3.0
[0045] 実施例 8 肥満状態改善剤含有オードトワレ調製 Example 8 Preparation of Eau De Toilette Containing Obesity Condition Improvement Agent
以下の処方例に基づき、常法によりオードトワレを調製した。  Based on the following formulation examples, eau de toilette was prepared by a conventional method.
処方例 2 :オードトワレ  Formulation Example 2: Eau De Toilette
(成分) (%)  (Ingredient) (%)
1 . ェタノ一ノレ 9 0 . 0  1 Etano 1 9 0. 0
2 . 精製水 7 . 0  2 Purified water 7.0
3 . δ— 3 _カレン 3 . 0  3. Δ— 3 _ Karen 3.0
[0046] 実施例 9 肥満状態改善剤含有ボディローションの調製 以下の処方例に基づき、常法によりボディローションを調製した。 Example 9 Preparation of Body Lotion Containing Obesity Condition Improvement Agent Based on the following formulation examples, a body lotion was prepared by a conventional method.
処方例 3:ボディローション Formulation Example 3: Body Lotion
(成分) (%) (Ingredient) (%)
1. 精製水 75. 51. Purified water 75.5
2. ェタノ一ノレ 1 0. 02. Etano 1 1 0. 0
3. グリセリン 5. 03. Glycerin 5.0
4. 1 , 3 -プチレンダリコール 9. 04.1, 3-Petit Render Recall 9.0
5. サイプレス精油 0. 5 5. Cypress essential oil 0.5
実施例 10 肥満状態改善剤含有ボディミルクの調製 Example 10 Preparation of body milk containing an obesity-improving agent
ボディミルクを下記手順により調製した。ボディミルクの処方は処方例 4のとおりであ る。  Body milk was prepared by the following procedure. The formula for body milk is shown in Formulation Example 4.
(ボディミルクの調製手順)  (Body milk preparation procedure)
最初に成分 1〜8を 70°Cで均一に混合し、混合物 Aを得た。成分 9〜: LOを 70°Cで均 一に混合溶解し、混合物 Aに添加して乳化する。この乳化物を冷却しながら、あらか じめ膨潤させた成分 11〜12、成分 13を添加して均一に混合し、ボディミルクを得た 処方例 4:ボディミルク First, components 1 to 8 were uniformly mixed at 70 ° C. to obtain a mixture A. Ingredient 9 ~: LO is uniformly mixed and dissolved at 70 ° C, and added to mixture A to emulsify. While this emulsion was cooled, ingredients 11-12 and 13 previously swollen were added and mixed uniformly to obtain body milk.Prescription Example 4: Body milk
(成分) ' (%)(Ingredients) '(%)
1. ステアリン酸 0. 21. Stearic acid 0.2
2. ジプロピレンダリコーノレ 4. 02. Dipropylene Darikonore 4.0
3. グリセリン 4. 03. Glycerin 4.0
4. 1, 3一プチレングリコ一-ル 2. 04. 1, 3 1-Putylene Glycol 2.0
5. モノォレイン酸ボリォキシエチレンソルビタン 〇 . 55. Boroxyethylene sorbitan monooleate 〇 .5
6. ベへニノレアノレコーノレ 0. 56. Behenino Reno Conorre 0.5
7. 2—ェチルへキサン酸トリグリセライド 2. 07. 2-Ethylhexanoic acid triglyceride 2.0
8. モノォレイン酸ボリォキシエチレンソルビタン 0. 58. Boroxyethylene sorbitan monooleate 0.5
9. 水酸化ナトリウム 〇 . 139. Sodium hydroxide ○ 13
10. 精製水 12, 8710. Purified water 12, 87
1 1 - 力ルボキシルビニルポリマー 0. 221 1-Forced Roxyl vinyl polymer 0.22
1 2. 精製水 残量1 2. Purified water remaining
1 3. δ— 3—力レン 0. 5 実施例 11 肥満状態改善剤含有ァロマオイルの調製 1 3. δ—3—Power Len 0.5 Example 11 Preparation of Aloma Oil Containing Obesity Improvement Agent
以下の処方例に基づき、常法によりァロマオイルを調製した。 実施例 12 肥満状態改善剤含有ァロマオイルの調製  Based on the following prescription examples, an aroma oil was prepared by a conventional method. Example 12 Preparation of Aloma Oil Containing Obesity Condition Improvement Agent
以下の処方例に基づき、常法によりァロマオイルを調製した。  Based on the following prescription examples, an aroma oil was prepared by a conventional method.
処方例 6:ァロマオイル  Formulation Example 6: Aroma Oil
(成分) (%)(Ingredient) (%)
1. 2—ェチルへキサン酸トリダリセライ ド 89. 01. 2-Ethylhexanoic acid tridallylide 89.0
2. ジプロピレンダリコール 10. 02. Dipropylene Dalicol 10.0
2. δ _ 3—カレン 1. 0 実施例 13 肥満状態改善剤含有ルームフレダランスの調製 2. δ_3-Karen 1.0 Example 13 Preparation of Room Frederance Containing Obesity Condition Reducing Agent
以下の処方例に基づき、常法によりルームフレダランスを調製した。  Based on the following formulation examples, room fredalance was prepared by a conventional method.
処方例 7:ルームフレグランス(エアゾール剤)  Formulation Example 7: Room Fragrance (Aerosol)
(成分) (%) (Ingredient) (%)
1. エタノ一ノレ 19. 5 1. Etano Nore 19.5
2. サイプレス精油 0. 52. Cypress essential oil 0.5
3. LPG 80. 0 3. LPG 80. 0
[0051] 実施例 14 肥満状態改善剤含有ルームフレダランスの調製 Example 14 Preparation of Room Frederance Containing Obesity Condition Improvement Agent
以下の処方例に基づき、常法によりルームフレダランスを調製した  Based on the following formulation examples, room fredalance was prepared by a conventional method.
処方例 8:ルームフレグランス(エアゾール剤)  Formulation Example 8: Room Fragrance (Aerosol)
1. ェタノ一ノレ 89. 5 1. Etano Nore 89.5
2. ジプロピレングリコール 10. 0  2. Dipropylene glycol 10.0
3. δ— 3—力レン 0, 5  3. δ— 3—Power Len 0, 5
[0052] 上記調製した肥満状態改善剤含有フレッシュコロン、肥満状態改善剤含有ボディ口 ーシヨン、肥満状態改善剤含有ァロマオイル、および肥満状態改善剤含有ルームフ レグランスのそれぞれは、不安な気分の改善や睡眠障害の改善力もたらされ、ストレ スの解消に有効であり、減量効果に優れるなど、優れた肥満状態改善効果を有する ことを確認できた。 [0052] Fresh colon containing an obesity condition improving agent prepared above, body mouth containing obesity condition improving agent, aroma oil containing obesity condition improving agent, and room fat containing obesity condition improving agent Each of the fragrances was confirmed to have an excellent effect of improving obesity, such as an improvement in anxious mood and an improvement in sleep disorder, which was effective in relieving stress and was excellent in weight loss.
本発明は次のような記載の発明も含む。  The present invention also includes the invention described below.
(1)サイプレス精油と基剤力 本質的に構成される組成物であって、肥満状態を改善 することができることを特徴とする新規組成物。  (1) Cypress essential oil and base power A composition essentially composed of a novel composition characterized by being able to improve obesity.
(2) δ 3—力レンと基剤から本質的に構成される組成物であって、肥満状態を改善 することができることを特徴とする新規組成物。  (2) A novel composition characterized in that it is a composition essentially composed of δ 3 -strength and a base and can improve obesity.
(3)サイプレス精油と基剤力 本質的に構成される組成物であって、肥満状態を改善 することができ、し力も抗鬱作用及び Ζ又はストレス低減作用をさらに有することを特 徴とする新規組成物。  (3) Cypress essential oil and base power It is a composition that is essentially composed, it can improve obesity, and the strength also has an antidepressant action and acupuncture or stress reduction action. New composition.
(4) δ 3—力レンと基剤から本質的に構成される組成物であって、肥満状態を改善 することができ、し力も抗鬱作用及び Ζ又はストレス低減作用をさらに有することを特 徴とする新規組成物。  (4) A composition consisting essentially of δ 3 -strength and a base, which is capable of improving obesity and also has an antidepressant action and an acupuncture or stress reducing action. New composition.
(5)サイプレス精油と基剤力 本質的に構成される組成物であって、肥満状態を改善 することができ、皮膚外用剤又は芳香剤として有用であることを特徴とする新規組成 物。  (5) Cypress essential oil and base power A composition essentially composed of a novel composition characterized in that it can improve obesity and is useful as a skin external preparation or fragrance.
(6) δ 3—力レンと基剤から本質的に構成される組成物であって、肥満状態を改善 することができ、皮膚外用剤又は芳香剤として有用であることを特徴とする新規組成 物。  (6) A novel composition characterized by comprising δ 3 -strength and a base, which can improve obesity and is useful as an external skin preparation or fragrance. object.
(7)上記新規組成物を皮膚に適用し、上記新規組成物力ゝらのサイプレス精油又は δ —3—カレン、あるいはサイプレス精油又は δ—3—カレンを含む揮発成分を体内に 取り入れることを特徴とする肥満状態を改善する方法。  (7) The above-mentioned new composition is applied to the skin, and the cypress essential oil or δ-3-carene or the volatile component containing Cypress essential oil or δ-3-calen from the above-mentioned new composition is incorporated into the body. To improve obesity.
(8)上記新規組成物を空気と自由に接触できるように保管し、前記新規組成物が保 管された空間の空気を介して、上記新規組成物からのサイプレス精油又は δ— 3— カレン、あるいはサイプレス精油又は δ 3—力レンを含む揮発成分を体内に取り入 れることを特徴とする肥満状態を改善する方法。  (8) The new composition is stored so that it can freely come into contact with air, and through the air in the space where the new composition is stored, Cypress essential oil or δ-3-calen from the new composition, Alternatively, a method for improving an obesity state, comprising incorporating a volatile component containing cypress essential oil or δ 3 -strength into the body.
(9)肥満状態改善のための、サイプレス精油又は δ 3—力レンを含む香料組成物 の使用 (9) A fragrance composition containing cypress essential oil or δ 3-strength for improving obesity Use of

Claims

請求の範囲 The scope of the claims
[1] サイプレス精油からなることを特徴とする肥満状態改善剤。  [1] An obesity improving agent comprising cypress essential oil.
[2] δ—3—カレン力 なることを特徴とする肥満状態改善剤。 [2] An agent for improving obesity, characterized by:
[3] 抗鬱作用及び Ζ又はストレス低減作用をさらに有することを特徴とする請求項 1又は [3] The method according to claim 1 or 2, further comprising an antidepressant action and an acupuncture or stress reducing action.
2記載の肥満状態改善剤。 2. The obesity condition-improving agent according to 2.
[4] 請求項 1〜3記載のいずれかの肥満状態改善剤を含有することを特徴とする皮膚外 用剤。 [4] A skin external preparation comprising the obesity-condition improving agent according to any one of claims 1 to 3.
[5] 請求項 1〜3記載のいずれかの肥満状態改善剤を含有することを特徴とする芳香剤 肥満状態改善のための、サイプレス精油又は δ 3—力レンを含む香料の使用方法  [5] A fragrance comprising the obesity condition-improving agent according to any one of claims 1 to 3, and a method of using a fragrance comprising cypress essential oil or δ3-strength for obesity condition improvement
PCT/JP2006/320476 2005-11-30 2006-10-13 Agent for improving obesity conditions WO2007063648A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2007547866A JP5814495B2 (en) 2005-11-30 2006-10-13 Obesity improving agent
TW095144356A TW200730185A (en) 2005-11-30 2006-11-30 Improving agent for obesity and usage thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005345543 2005-11-30
JP2005-345543 2005-11-30

Publications (1)

Publication Number Publication Date
WO2007063648A1 true WO2007063648A1 (en) 2007-06-07

Family

ID=38091988

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/320476 WO2007063648A1 (en) 2005-11-30 2006-10-13 Agent for improving obesity conditions

Country Status (3)

Country Link
JP (1) JP5814495B2 (en)
TW (1) TW200730185A (en)
WO (1) WO2007063648A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011051970A (en) * 2009-08-07 2011-03-17 Kose Corp Perfume composition for use in sleep improvement, and cosmetic containing the same, and method for improving sleep
JP2021031458A (en) * 2019-08-27 2021-03-01 中野Bc株式会社 Heat-producing protein expression promoter

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003113392A (en) * 2001-10-04 2003-04-18 Kiyomitsu Kawasaki Perfuming/deodorizing composition and perfuming/ deodorizing agent for human body containing the perfuming/deodorizing composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003113392A (en) * 2001-10-04 2003-04-18 Kiyomitsu Kawasaki Perfuming/deodorizing composition and perfuming/ deodorizing agent for human body containing the perfuming/deodorizing composition

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ARAI S.: "Saishin Koryo no Jiten", KABUSHIKI KAISHA ASAKURA SHOTEN, 2000, pages 229 - 230, XP003013647 *
DAVIES P. ET AL: "Aromatherapi Jiten", FRAGRANCE JOURNAL, 1997, pages 298 - 299, XP003013648 *
INTO M.: "Gosei Koryo Kagaku to Shohin Chishiki", THE CHEMICAL DAILY CO. LTD., 1996, pages 26 - 27, XP003013646 *
JAPAN PERFUMERY & FLAVORING ASSOCIATION: "Kaori no Soga Jiten", KABUSHIKI KAISHA ASAKURA SHOTEN, 1998, pages 113 - 114, XP003013645 *
ROSE J. ET AL: "Essential Oil & Herb Water 375", BAB JAPAN CO. LTD., 2004, pages 356 - 357, XP003013644 *
TISSERAND R. ET AL: "aromatherapy <Hoko Ryoho> no Riron to Jissai", FRAGRANCE JOURNAL, 1985, pages 221 - 223, XP003013643 *
YATAGAI M.: "Kaori no Hyakka Jiten", MARUZEN CO.LTD., 31 January 2005 (2005-01-31), pages 60,69, - 843-844, XP003013642 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011051970A (en) * 2009-08-07 2011-03-17 Kose Corp Perfume composition for use in sleep improvement, and cosmetic containing the same, and method for improving sleep
JP2021031458A (en) * 2019-08-27 2021-03-01 中野Bc株式会社 Heat-producing protein expression promoter
JP7298841B2 (en) 2019-08-27 2023-06-27 中野Bc株式会社 thermogenic protein expression promoter

Also Published As

Publication number Publication date
JP5814495B2 (en) 2015-11-17
TW200730185A (en) 2007-08-16
JPWO2007063648A1 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
JP5093998B2 (en) Pigmentation preventing or improving agent
CN105640870B (en) A kind of skin care compositions and methods and skin nursing products containing yeast extract
KR101500191B1 (en) Skin care compositions and method for manufacturing the same
CN113230170A (en) Double-continuous-phase cleansing oil with effects of cleaning and nourishing skin and preparation method thereof
CN114796024B (en) Bionic sebum composition for skin barrier repair, and preparation method and application thereof
US20210038632A1 (en) Compositions and methods for treating vaginal atrophy
JPH08283139A (en) Dermal preparation for external use
KR100875042B1 (en) Cosmetic composition and how to create a refreshing sense of sensory organs
CN1357321A (en) Inflammation and red spot reducing method
JP2005145871A (en) Cosmetic
WO2007063648A1 (en) Agent for improving obesity conditions
JP2008247894A (en) Stress response ameliorating agent
JP2004217615A (en) Cosmetic for improving psychological condition
JP3996488B2 (en) Emulsified cosmetics
JP2007008912A (en) Method of cosmetic treatment for maintaining homeostasis of rhythm of life
JP2001207188A (en) Perfume composition for eliminating lipid peroxide
CN105534830B (en) A kind of maintenance method of bandage type body film and body skin
JP2013129638A (en) Cosmetic material
JP2008169196A (en) External preparation for skin
CN112088010A (en) Compositions and methods for treating vaginal dryness
CN104983626A (en) Beauty and skin care composition containing acer truncatum oil and preparation method of beauty and skin care composition
JP5159241B2 (en) Ligament cell activator
JPS617206A (en) Cell activator
KR100521787B1 (en) Composition for enhancing skin or hair
RU2376974C2 (en) Transdermal gel for face &#39;stvolin&#34;

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2007547866

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06811754

Country of ref document: EP

Kind code of ref document: A1